nicotine has been researched along with n-(1-methylethyl)-1,1,2-trimethylpropylamine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, JH; Hu, G; Li, Z; Liu, Q; Liu, SY; Wu, J | 1 |
| DeChon, J; Hu, G; Hu, J; Liu, Q; Wu, J; Yan, KC | 1 |
| Bevins, RA; Charntikov, S; Fink, K; Fleckenstein, AE; Hadlock, GC; Hu, G; Li, M; Pittenger, S; Schepers, S; Swalve, N | 1 |
3 other study(ies) available for nicotine and n-(1-methylethyl)-1,1,2-trimethylpropylamine
| Article | Year |
|---|---|
Iptakalim inhibits nicotine-induced enhancement of extracellular dopamine and glutamate levels in the nucleus accumbens of rats.
Topics: Analysis of Variance; Animals; Chromatography, High Pressure Liquid; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Extracellular Space; Glutamic Acid; Nicotine; Nicotinic Agonists; Nucleus Accumbens; Propylamines; Rats | 2006 |
Iptakalim inhibits nicotinic acetylcholine receptor-mediated currents in dopamine neurons acutely dissociated from rat substantia nigra pars compacta.
Topics: Acetylcholine; Action Potentials; Animals; Dopamine; gamma-Aminobutyric Acid; Glutamic Acid; In Vitro Techniques; Membrane Potentials; N-Methylaspartate; Neurons; Neurotransmitter Agents; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Patch-Clamp Techniques; Propylamines; Rats; Rats, Wistar; Receptors, Nicotinic; Substantia Nigra | 2006 |
Iptakalim attenuates self-administration and acquired goal-tracking behavior controlled by nicotine.
Topics: Animals; Conditioning, Operant; Dopamine; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Interactions; Goals; Male; Membrane Transport Modulators; Motor Activity; Nicotine; Nicotinic Agonists; Propylamines; Rats; Rats, Sprague-Dawley; Self Administration; Serotonin; Tritium | 2013 |